Preliminary Results on Predation of Gypsy Moth Pupac during a Period of Latency in Slovakia

Proceedings : IUFRO Kanazawa 2003 "Forest Insect Population Dynamics and Host Influences"., Scedule:14－19 September 2003, Vemue: Kanazawa Citymonde Hotel, Kanazawa, Japan, Joint metting of IUFRO working groups : 7.01.02 Tree resistance to Insects | 7.03.06 Integrated management of forset defoloating insects | 7.03.07 Population dynamics of forest insects, Sponsored by: IUFRO-J | Ishikawa Prefecture | Kanazawa City | 21st-COE Program of Kanazawa University, Editors: Kamata, Naoto | Liebhold, Nadrew M. | Quiring, Dan T. | Clancy, Karen M

Assessment of the stability of new chemotherapeutic selenium-kojic acid derivative using HPLC and MS analysis

ABSTRACT The stability of the new chemotherapeutic selenium kojic acid derivative, 5-benzyloxy-2-selenocyanatomethyl-4-pyranone (P763), was evaluated in simulated gastric and intestinal fluids as well as in human plasma at 37 o C ± 1. A stability-indicating HPLC procedure with C8 RP column and a mobile phase of acetonitrile/water (1:1) at a flow rate 1 ml/min was used. The eluted P763 compound and its degradation products were detected at 254 nm. The accelerated stability profiles were established. Kinetic studies under controlled experimental conditions have proved that P763 underwent fast hydrolysis in simulated intestinal fluid (phosphate buffer solution, pH 7.4), however the compound showed an appropriate stability at gastric acid solution (0.1M HCl solution) and in human plasma. The kinetics have indicated that the compound's degradation followed pseudo first-order reaction with relatively higher k deg and lower t 1/2 and t 90 values in simulated intestinal fluid compared to those in simulated gastric acid solution and plasma. The degradation of P763 compound at basic solution was confirmed by MS and MS/MS analysis, where the characteristic signals of the molecular (m/z 322) and fragment (m/z 91, 198) mass ions of compound disappeared. The obtained results suggest that the stability of P763 compound should be considered for future biopharmaceutical and biological studies

New international long-term ecological research on air pollution effects on the Carpathian Mountain forests, Central Europe

An international cooperative project on distribution of ozone in the Carpathian Mountains, Central Europe was conducted from 1997 to 1999. Results of that project indicated that in large parts of the Carpathian Mountains, concentrations of ozone were elevated and potentially phytotoxic to forest vegetation. That study led to the establishment of new long-term studies on ecological changes in forests and other ecosystems caused by air pollution in the Retezat Mountains, Southern Carpathians, Romania and in the Tatra Mountains, Western Carpathians on the Polish-Slovak border. Both of these important mountain ranges have the status of national parks and are Man & the Biosphere Reserves. In the Retezat Mountains, the primary research objective was to evaluate how air pollution may affect forest health and biodiversity. The main research objective in the Tatra Mountains was to evaluate responses of natural and managed Norway spruce forests to air pollution and other stresses. Ambient concentrations of ozone (O3), sulfur dioxide (SO2), nitrogen oxides (NOx) as well as forest health and biodiversity changes were monitored on densely distributed research sites. Initial monitoring of pollutants indicated low levels Of O3, SO2, and NOx in the Retezat Mountains, while elevated levels of O3 and high deposition of atmospheric sulfur (S) and nitrogen (N) have characterized the Tatra Mountains. In the Retezat Mountains, air pollution seems to have little effect on forest health; however, there was concern that over a long time, even low levels of pollution may affect biodiversity of this important ecosystem. In contrast, severe decline of Norway spruce has been observed in the Tatra Mountains. Although bark beetle seems to be the immediate cause of that decline, long-term elevated levels of atmospheric N and S depositions and elevated O3 could predispose trees to insect attacks and other stresses. European and US scientists studied pollution deposition, soil and plant chemistry, O3-sensitive plant species, forest insects, and genetic changes in the Retezat and Tatra Mountains. Results of these investigations are presented in a GIS format to allow for a better understanding of the changes and the recommendations for effective management in these two areas

Prognostic and therapeutic impact of Argininosuccinate Synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging

[[abstract]]Targeted therapies have yet to have significant impact on the survival of patients with bladder cancer. In this study, we focused on the urea cycle enzyme argininosuccinate synthetase 1 (ASS1) as a therapeutic target in bladder cancer, based on our discovery of the prognostic and functional import of ASS1 in this setting. ASS1 expression status in bladder tumors from 183 Caucasian and 295 Asian patients was analyzed, along with its hypothesized prognostic impact and association with clinicopathologic features, including tumor size and invasion. Furthermore, the genetics, biology, and therapeutic implications of ASS1 loss were investigated in urothelial cancer cells. We detected ASS1 negativity in 40% of bladder cancers, in which multivariate analysis indicated worse disease-specific and metastasis-free survival. ASS1 loss secondary to epigenetic silencing was accompanied by increased tumor cell proliferation and invasion, consistent with a tumor-suppressor role for ASS1. In developing a treatment approach, we identified a novel targeted antimetabolite strategy to exploit arginine deprivation with pegylated arginine deiminase (ADI-PEG20) as a therapeutic. ADI-PEG20 was synthetically lethal in ASS1-methylated bladder cells and its exposure was associated with a marked reduction in intracellular levels of thymidine, due to suppression of both uptake and de novo synthesis. We found that thymidine uptake correlated with thymidine kinase-1 protein levels, and that thymidine levels were imageable with [18F]-fluoro-L-thymidine (FLT)-positron emission tomography (PET). In contrast, inhibition of de novo synthesis was linked to decreased expression of thymidylate synthase and dihydrofolate reductase. Notably, inhibition of de novo synthesis was associated with potentiation of ADI-PEG20 activity by the antifolate drug pemetrexed. Taken together, our findings argue that arginine deprivation combined with antifolates warrants clinical investigation in ASS1-negative urothelial and related cancers, using FLT-PET as an early surrogate marker of response

Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry : the ABRF glycoprotein research multi-institutional study 2012

One of the principal goals of glycoprotein research is to correlate glycan structure and function. Such correlation is necessary in order for one to understand the mechanisms whereby glycoprotein structure elaborates the functions of myriad proteins. The accurate comparison of glycoforms and quantification of glycosites are essential steps in this direction. Mass spectrometry has emerged as a powerful analytical technique in the field of glycoprotein characterization. Its sensitivity, high dynamic range, and mass accuracy provide both quantitative and sequence/structural information. As part of the 2012 ABRF Glycoprotein Research Group study, we explored the use of mass spectrometry and ancillary methodologies to characterize the glycoforms of two sources of human prostate specific antigen (PSA). PSA is used as a tumor marker for prostate cancer, with increasing blood levels used to distinguish between normal and cancer states. The glycans on PSA are believed to be biantennary N-linked, and it has been observed that prostate cancer tissues and cell lines contain more antennae than their benign counterparts. Thus, the ability to quantify differences in glycosylation associated with cancer has the potential to positively impact the use of PSA as a biomarker. We studied standard peptide-based proteomics/glycomics methodologies, including LC-MS/MS for peptide/glycopeptide sequencing and label-free approaches for differential quantification. We performed an interlaboratory study to determine the ability of different laboratories to correctly characterize the differences between glycoforms from two different sources using mass spectrometry methods. We used clustering analysis and ancillary statistical data treatment on the data sets submitted by participating laboratories to obtain a consensus of the glycoforms and abundances. The results demonstrate the relative strengths and weaknesses of top-down glycoproteomics, bottom-up glycoproteomics, and glycomics methods.17 page(s